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or ABACKGROUND Alcohol-induced cardiotoxicity is incompletely understood. Specifically, the long-term impact of
alcohol use on ventricular remodeling or dysfunction, its modulators, and effect thresholds among young adults remain
controversial.
OBJECTIVES The authors sought to evaluate a potential relationship between alcohol intake and cardiac remodeling,
assessed by echocardiography, over 20 years of follow-up.
METHODS Among the CARDIA (Coronary Artery Risk Development in Young Adults) study cohort, the authors studied
all subjects without baseline heart disorders who provided adequate information on their drinking habits and underwent
echocardiographic evaluation at years 5 and 25 of the study. The echocardiographic outcomes were left ventricular (LV)
ejection fraction, indexed LV end-diastolic volume and LV mass, and left atrial diameter. Participants were grouped
according to their weighted-average weekly drinking habits. An additional analysis used the estimated cumulative alcohol
consumption. Regression models and multivariable fractional polynomials were used to evaluate the association between
alcohol consumption and the outcomes.
RESULTS Among the 2,368 participants, alcohol consumption was an independent predictor of higher indexed LV mass
(p ¼ 0.014) and indexed LV end-diastolic volume (p ¼ 0.037), regardless of sex. No significant relationship between
alcohol intake and LV ejection fraction was found. Drinking predominantly wine was associated with less cardiac
remodeling and there was a nonsignificant trend for a harmful effect of binge drinking.
CONCLUSIONS After 20 years of follow-up, alcohol intake was associated with adverse cardiac remodeling, although it
was not related with LV systolic dysfunction in this initially healthy young cohort. Our results also suggest that drinking
predominantly wine associates with less deleterious findings in cardiac structure. (J Am Coll Cardiol 2018;72:1452–62)
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BMI = body mass index
BSA = body surface area
FP = fractional polynomials
LA = left atrial
LV = left ventricular
LVEDV = left ventricular end-
diastolic volume
LVEF = left ventricular
ejection fraction
NIAAA = National Institute of
Alcohol Abuse and AlcoholismI n 2013, 70% of U.S. adults reported drinking alco-holic beverages in the past year, and 7% had analcohol use disorder (1). Alcohol abuse is a
known risk factor for the development of alcoholic
cardiomyopathy (ACM) (2,3), which presents as a
dilated cardiomyopathy that can lead to heart failure
(4,5).
ACM is usually a presumptive diagnosis reserved
for patients with a history of “at risk” drinking (for
women, >3 drinks on any single day and >7 drinks per
week; for men, >4 drinks on any single day and >14
drinks per week, as per the National Institute of
Alcohol Abuse and Alcoholism [NIAAA] classifica-
tion), left ventricular (LV) systolic dysfunction, and
increased LV volumes, without other known cause to
justify their cardiac impairment (5–7).SEE PAGE 1463“Idiopathic” nonischemic dilated cardiomyopathy
is often diagnosed in patients who also report a his-
tory of alcohol intake, albeit generally mild to mod-
erate (7,8). Previous observational studies have
shown that approximately one-third of those diag-
nosed with dilated cardiomyopathy report an exces-
sive alcohol intake (9,10) and that alcohol abstinence
can significantly improve both LV function and
symptomatic heart failure (11). Furthermore, alcohol
may also lead to other cardiac diseases besides
LV dysfunction, such as arrhythmias (12) or hyper-
tension (13).
However, the relationship between alcohol intake
and cardiac disease does not seem to be linear (14)
and, in fact, mild-to-moderate alcohol (up to 1 stan-
dardized drink per day for women and up to 2 drinks
per day for men) consumption may even be beneficial
for coronary artery disease (15) and incident heart
failure (16,17).
Previous studies have shown an association be-
tween alcohol and subtle echocardiographic changes
in cardiac morphology and function, systolic and
diastolic (18,19). However, most studies are either
cross sectional (19) or performed over a short follow-
up period in middle-aged and older individuals (18).
We lack information about the long-term effect of
alcohol intake in young adults, and there is still
controversy about the impact of other patients’
characteristics or the pattern of alcohol intake
regarding the threshold level for being injurious.
Clarifying these issues related to alcohol’s car-
diotoxicity could have a significant impact in public
health.
The main goal of this study was to assess the po-
tential cardiotoxic role of alcohol in cardiac structure
and function over 20 years of follow-up during youngDownloaded for Ana Quininha (ana.quininha@chlc.min-saude.pt) at
For personal use only. No other uses withouadulthood into middle age. We hypothesized
that alcohol intake would be associated with
LV systolic impairment and dilatation.
Furthermore, we explored whether particular
population subgroups, specific types of alco-
holic beverages, and specific drinking pat-
terns modify such associations.
METHODS
STUDY SAMPLE. The CARDIA (Coronary Ar-
tery Risk Development in Young Adults)
cohort study recruited 5,115 apparently
healthy black and white individuals between
18 and 30 years of age, stratified by age, race,
sex, and educational level. Enrollment was
performed between 1985 and 1986 in 4 North Amer-
ican urban centers (Birmingham, Alabama; Chicago,
Illinois; Minneapolis, Minnesota; and Oakland, Cali-
fornia). Participants provided written informed con-
sent at each examination, and institutional review
boards from each field center and the coordinating
center approved the study annually.
Participants have been followed for >30 years and
have undergone a series of questionnaires and ex-
aminations at years 0, 2, 5, 7, 10, 15, 20, 25, and 30.
Detailed information regarding the design and pro-
cedures performed during the study have been pub-
lished elsewhere (20–22).
We considered year 5 of the CARDIA study as the
baseline period of our sample, because it was the first
year echocardiographic evaluations were performed.
The follow-up period of our study comprised a total
of 20 years (i.e., from year 5 until year 25, when a
follow-up echocardiogram was obtained).
During this period, 3,498 participants fulfilled
attendance criteria. Participants who, at baseline, had
either known heart disease (questioned as “has a
doctor or a nurse ever said that you have heart
problems?”) or a left ventricular ejection fraction
(LVEF) below 55% were excluded from the analysis
(n ¼ 358). Furthermore, we also excluded participants
with insufficient information about the echocardio-
graphic outcomes (n ¼ 246) and those who did not
provide sufficient information regarding their alcohol
consumption habits (i.e., participants who did not
respond to the alcohol questionnaires at least at years
5, 15, and 25 of the CARDIA study) (Figure 1). Reten-
tion rates were 86% at year 5, 74% at year 15, and 72%
at year 25; >90% of initial participants have main-
tained contact over time.
ALCOHOL CONSUMPTION ASSESSMENT. Data regarding
alcohol intake were obtained from a questionnaire
filled in by the CARDIA study participants at years 5, Hospital Centre of Central Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
t permission. Copyright ©2020. Elsevier Inc. All rights reserved.







1,616 did not attend year 25
358 with exclusion criteria at year 5
269 had known heart disease
89 had LVEF <55%
772 with missing relevant data
246 had missing echocardiographic data
(LVEF and LVEDV) at year 25
526 had missing data on alcohol consumption*
*Participants who did not respond to the alcohol questionnaires at least at years 5, 15,
and 25 of the CARDIA study. LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left
ventricular ejection fraction.
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Downloaded fo15, and 25. At each examination, participants were
questioned regarding their past drinking habits and,
specifically, the number of drinks of wine, beer, and
liquor they typically consumed per week.
Using visual aids for estimating a typical drink, the
number of drinks of wine, beer, and liquor typically
consumed in a week was assessed. The average
alcohol consumption per week was calculated
assuming that the amount of ethanol in 1 drink of
beer, wine, and liquor was 16.7 ml, 17.0 ml, and
19.2 ml, respectively. This total was then divided by
17.24 ml (the amount of ethanol in an average drink,
corresponding to 14 g of alcohol) to obtain the num-
ber of standardized drinks per week (20,23). This
estimation of standard drinks was used to categorize
alcohol intake in all the analyses.
We used a modified version of the NIAAA classifi-
cation (24) to describe alcohol intake, estimating the
average consumption of standard drinks per week
(self-reported at years 5, 15, and 25), divided into the 5
following groups: alcohol abstainers (no alcohol
consumption); participants who consumed on
average >0 and <4 standardized drinks per week
(very low risk); $4 and <7 (low risk); $7 and <14 (at
risk), and $14 (high risk).
We also estimated the cumulative alcohol con-
sumption during the 20 years of follow-up by calcu-
lating the product of the average ethanol intake per
year (using the reported intake of alcohol per day at
year 5 of the study, year 15, and year 25) and the total
time interval (20 years). The effect of sex and race onr Ana Quininha (ana.quininha@chlc.min-saude.pt) at Hospital Centre of Cent
For personal use only. No other uses without permission. Copyrightthe exposure outcomes was analyzed, which was
facilitated by the stratified enrollment of CARDIA.
In order to be able to evaluate potential differences
in the cardiotoxic effect of alcohol according to vari-
ations in consumption habits, we also extracted in-
formation from those 3 questionnaires equally
distributed in time regarding the participants’ inges-
tion of particular types of beverages (namely beer,
wine, or liquor) and their drinking patterns (specif-
ically evaluating self-reported binge-drinking,
defined as the consumption of more 5 or more stan-
dardized drinks on the same occasion, at least once
within the last 30 days).
ECHOCARDIOGRAPHIC EVALUATION. Our primary
endpoint to assess LV systolic function was LVEF.
Secondary endpoints were body surface area (BSA)-
indexed LV end-diastolic volume (LVEDV) (a marker
of LV dilation and ventricular remodeling with a sig-
nificant prognostic value [25,26]), BSA-indexed LV
mass (another marker of ventricular remodeling [25]),
and left atrial (LA) diameter (which has been
previously associated with adverse cardiovascular
events [27]). LVEDV and LVEF measurements were
performed by transthoracic echocardiography, using
2-dimensional apical views, whereas M mode was
used to assess both BSA-indexed LV mass and LA
diameter (the original values were used).
All studies were digitally recorded using an Artida
Cardiac Ultrasound Scanner (Toshiba Medical Sys-
tems, Otawara, Japan) and assessed by certified
analysts at the Johns Hopkins University Echocardi-
ography Reading Center (Baltimore, Maryland), using
standard image analysis software (Digisonics, Hous-
ton, Texas). These endpoints were assessed at year
25, but we also considered the individual variation
(between year 25 and year 5) of the echocardiographic
parameters in one of the models.
COVARIATES AND POTENTIAL CONFOUNDERS.
Several variables were considered as potentially
confounding factors, namely: sex, age, race, hyper-
tension (in the CARDIA questionnaire: “has a doctor
or a nurse ever said you have high blood pressure or
hypertension?”), dyslipidemia (according to the
CARDIA questionnaire: “has a doctor or a nurse ever
said you have high blood cholesterol?”), diabetes
(self-reported or taking medication), family history of
cardiovascular diseases, body mass index (BMI), self-
reported tobacco or illicit drug use, educational level
(up to high school or above that), physical activity
(using a questionnaire about the duration and in-
tensity of self-reported participation in 13 categories
of exercise over the previous 12 months [28]), chronic
pulmonary disease, obstructive sleep apnea, thyroidral Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
 ©2020. Elsevier Inc. All rights reserved.













(n ¼ 192) p Value
Age, yrs 51 (47–53) 50 (47–53) 51 (47–53) 51 (48–53) 51 (48–53) 51 (47–53) 0.171
Sex
Men 1,051 (44.4) 192 (31.0) 373 (40.0) 146 (48.2) 185 (57.8) 155 (80.7) <0.001
Race
White 1,356 (57.3) 258 (42.7) 560 (60.0) 202 (66.7) 218 (68.1) 118 (61.5) <0.001
Black 1,006 (42.5) 359 (58.0) 371 (39.7) 101 (33.3) 101 (31.6) 74 (38.5)
Other 6 (0.2) 2 (0.32) 3 (0.32) 0 (0.0) 1 (0.31) 0 (0.0)
Educational level*
High school or above 1,593 (67.3) 384 (62.0) 659 (70.6) 221 (72.9) 223 (69.7) 106 (55.2) <0.001
Below high school 775 (32.7) 235 (38.0) 275 (29.4) 82 (27.1) 97 (30.3) 86 (44.8)
Physical activity*
Low 492 (20.9) 149 (24.2) 212 (22.8) 47 (15.6) 53 (16.6) 31 (16.3) <0.001
Moderate 1,059 (44.9) 302 (49.0) 399 (43.0) 143 (47.4) 144 (45.1) 71 (37.4)
High 806 (34.2) 166 (26.9) 318 (34.2) 112 (37.1) 122 (38.2) 88 (46.3)
Body mass index, kg/m2
<18.5 17 (0.7) 5 (0.8) 7 (0.8) 1 (0.33) 3 (0.94) 1 (0.52) <0.001
18.5–25.0 632 (26.7) 122 (19.7) 258 (27.7) 103 (34.0) 94 (29.5) 55 (28.7)
25.0–30.0 779 (32.9) 164 (26.5) 304 (32.6) 106 (35.0) 127 (39.8) 78 (40.6)
>30.0 938 (39.6) 328 (53.0) 364 (39.0) 93 (30.7) 95 (29.8) 58 (30.2)
Relevant medical history
Smoking† 386 (43.4) 46 (32.2) 116 (36.9) 58 (42.7) 76 (49.0) 90 (64.8) <0.001
Illicit drug use‡ 959 (40.6) 139 (22.5) 349 (37.5) 146 (48.2) 182 (57.1) 143 (75.3) <0.001
Cerebrovascular disease 41 (1.7) 14 (2.27) 17 (1.82) 3 (0.99) 4 (1.26) 3 (1.56) 0.711
Peripheral arterial disease 28 (1.2) 10 (1.6) 11 (1.2) 2 (0.7) 2 (0.6) 3 (1.6) 0.636
Hypertension 737 (31.2) 229 (37.1) 258 (27.7) 94 (31.1) 94 (29.6) 62 (32.5) 0.003
Diabetes mellitus 220 (9.3) 85 (13.8) 83 (8.9) 17 (5.6) 23 (7.2) 12 (6.3) <0.001
Dyslipidemia 685 (29.0) 185 (29.9) 262 (28.1) 98 (32.5) 75 (23.6) 65 (34.0) 0.056
Renal disease 144 (6.1) 43 (7.0) 57 (6.1) 18 (6.0) 19 (6.0) 7 (3.7) 0.586
Liver disease 63 (2.7) 15 (2.4) 22 (2.4) 11 (3.6) 7 (2.2) 8 (4.2) 0.478
Thyroid disease 206 (8.7) 72 (11.7) 87 (9.3) 20 (6.6) 19 (6.0) 8 (4.2) 0.002
Obstructive sleep apnea 222 (9.4) 70 (11.3) 85 (9.1) 31 (10.3) 20 (6.3) 16 (8.3) 0.140
Chronic pulmonary disease§ 24 (1.0) 5 (0.8) 8 (0.9) 3 (1.0) 5 (1.6) 3 (1.6) 0.653
Other cardiac diseasesk 151 (6.4) 39 (6.3) 61 (6.6) 23 (7.6) 19 (6.0) 9 (4.7) 0.774
Familiar cardiovascular disease 20 (0.9) 9 (1.5) 5 (0.5) 4 (1.3) 2 (0.6) 0 (0.0) 0.180
Values are median (interquartile range) or n (%). Average alcohol intake per week was estimated using the questionnaires at year 5 of the CARDIA study (baseline), year 15 and
year 25, as specified in the Methods section. The p value for trend is represented. *All the characteristics were considered if present in any given time over the 20 years of
follow-up, except for educational level, physical activity and body mass index, which are relative to baseline only. †Defined as the consumption of cigarettes, cigars, tobacco
pipe or smokeless tobacco regularly for at least 3 months. ‡Including cocaine, heroin, amphetamines and methamphetamines (cannabinoids were not taken into account for this
parameter). §Specifically asthma, chronic bronchitis or emphysema. kOther than dilated cardiomyopathy, specifically ischemic and valvular heart disease.
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1455disease, liver disease, cerebrovascular disease, pe-
ripheral artery disease. or renal disease (Table 1).
These variables were assessed at year 25, when we
analyzed the echocardiographic outcomes, because
the questionnaire asked whether the participants
ever had one of these diagnoses or characteristics,
and we wanted to adjust for them if they were present
at baseline or were detected during follow-up; the
exceptions were educational level, physical activity,
and BMI, which are relative to baseline only. These
possible confounders were selected based on clinical
relevance and have been described elsewhere (21);
the respective questionnaires are available at theDownloaded for Ana Quininha (ana.quininha@chlc.min-saude.pt) at
For personal use only. No other uses withouCARDIA website. Furthermore, we also accounted for
the development of ischemic or valvular heart disease
(“other cardiac diseases,” defined as the occurrence
of myocardial infarction, angina, rheumatic fever, or
valvular disease) during the study period as a po-
tential confounder. We also adjusted for baseline
echocardiographic values (at year 5).
STATISTICAL ANALYSES. Descriptive statistics and
the prevalence of the baseline covariates were
determined for the 5 previously mentioned NIAAA
alcohol intake groups. The distribution of covariates
was compared among the groups using either the Hospital Centre of Central Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
t permission. Copyright ©2020. Elsevier Inc. All rights reserved.
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Downloaded fochi-square test or Fisher’s exact test (for categorical
variables, wherever adequate), analysis of variance
(for continuous variables, followed by pairwise com-
parison with Bonferroni adjustment for multiple
comparisons whenever necessary), or Kruskal-Wallis
test (for continuous variables without a normal dis-
tribution). Categorical variables were expressed as
frequencies. Continuous variables were expressed as
mean  SD if normally distributed, or median and
interquartile range if not normally distributed. The
normality of distribution was investigated using the
Kolmogorov-Smirnov test.
In order to assess the relationship between alcohol
consumption and LV dysfunction, the various echo-
cardiographic outcome parameters were analyzed
using unadjusted and multivariable regression anal-
ysis, namely linear regression (considering the out-
comes as continuous variables), accounting for the
before-mentioned potential confounders in the
multivariable models.
In model 1, alcohol consumption was introduced as
a categorical variable (i.e., average number of stan-
dard drinks per week, distributed into the 5 NIAAA
categories). In model 2, alcohol intake was a contin-
uous variable (i.e., estimated cumulative alcohol
consumption in liters during the 20 years of follow-
up). Covariates used for multivariable analysis were
chosen based on unadjusted analysis (p < 0.10) and
clinical significance.
As a sensitivity analysis, we also performed inverse
probability weighted regression adjustment. We
compared each category of alcohol intake with ab-
stainers, which was the reference group. To study a
possible nonlinear relationship between average
alcohol intake and the echocardiographic parameters,
we used multivariable fractional polynomials (FP) as
a closed test procedure (29) (Model 3).
To assess whether race or sex modified the rela-
tionship between cumulative alcohol consumption
and our pre-defined outcomes, we analyzed the po-
tential for an interaction between these variables and
alcohol consumption.
Finally, subgroup analysis was performed to eval-
uate the association of specific types of beverages and
binge drinking on our main echocardiographic out-
comes. A p value below 0.05 was considered statisti-
cally significant. The statistical analyses were
performed using Stata Software version 13 (Stata
Corp, College Station, Texas).
RESULTS
In total, 2,368 participants were included in the
analysis (Figure 1). Their median age at the end of ther Ana Quininha (ana.quininha@chlc.min-saude.pt) at Hospital Centre of Cent
For personal use only. No other uses without permission. Copyrightstudy was 51 years of age (interquartile range: 47 to 53
years). In total, 44.4% (n ¼ 1,051) were male and
57.3% (n ¼ 1,356) were Caucasian.
The majority of participants either did not
consume alcohol or drank <4 standard drinks per
week (Table 1). The average daily ethanol intake was
10 ml, and only 8.1% (n ¼ 192) of the participants were
“at risk” drinkers, with a weekly alcoholic intake
above 14 drinks per week. The estimated mean cu-
mulative alcohol intake was 82  130 l over 20 years
(mean of 13 drink-years).
LVEF, END-DIASTOLIC VOLUME AND MASS, AND LA
DIAMETER AT THE END OF FOLLOW-UP. The cova-
riates used for adjustment were sex, race, age,
educational level, smoking, hypertension, diabetes,
BMI, dyslipidemia, illicit drug use, and “other cardiac
diseases” (namely, heart attack, angina, mitral valve
prolapse, or rheumatic heart disease) at year 25, as
well as the echocardiographic values at baseline (year
5). As stated in the Methods section, covariates were
chosen based on unadjusted analysis (Table 1) and
clinical significance (in the case of age and “other
cardiac diseases”).
We did not find an overall significant association
between cumulative alcohol intake and LVEF, even
though the first category of alcohol intake had a
subtle increase in LVEF, both in conventional and
inverse probability weighted adjustment (Table 2,
Online Table 1). Only 76 participants (3.2%) had
LVEF <50% at the end of follow-up, and the rela-
tionship between alcohol intake and LVEF as a
dichotomous variable was similar to that seen as a
continuous variable (not significant overall).
There was a progressive and statistically significant
increase in BSA-indexed LVEDV with increasing
alcohol intake, which remained statistically signifi-
cant after adjustment (53.1  10.7 ml/m2 in non-
drinkers vs. 58.8  14.8 ml/m2 if >14 drinks/week;
p ¼ 0.037) (Table 2). Using inverse probability
weighted regression adjustment testing a linear
model, this lost significance (Online Table 1). How-
ever, using an adjusted analysis with FP, this rela-
tionship was also significant, but best defined as
nonlinear (model 3, in which age was also included as
a nonlinear covariate) (Online Table 2). If we analyzed
BSA-indexed LVEDV as a dichotomous variable
(considering $75 ml/m2 as abnormal, which is true for
both males and females), 131 participants (5.5%) had
an increased value at the end of follow-up, and there
was a significant association with alcohol intake.
A significant and linear association was found be-
tween alcohol intake and BSA-indexed LV mass,
which remained after adjustment for covariatesral Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
 ©2020. Elsevier Inc. All rights reserved.
TABLE 2 Echocardiographic Outcomes at Year 25 According to Alcohol Consumption
Model 1: Standard Drinks per Week















LVEF, % 61.6  7.2 61.2  7.4 62.0  6.7 61.4  7.8 61.4  7.2 61.4  7.5
Unadjusted Reference 0.81 (0.08 to 1.55);
0.029
0.21 (0.78 to 1.21);
0.672
0.19 (0.78 to 1.17);
0.695
0.26 (0.91 to 1.43);
0.666
0.842
Adjusted Reference 1.84 (0.08 to 3.60);
0.040
0.32 (2.38 to 1.73);
0.758
1.30 (0.65 to 3.26);
0.192
0.37 (1.91 to 2.65);
0.752
0.907
BSA-indexed LVEDV, ml/m2 55.5  12.4 53.1  10.7 55.3  12.2 56.8  13.1 57.0  12.4 58.8  14.8
Unadjusted Reference 2.21 (0.96 to 3.45);
0.001
3.68 (2 to 5.37);
0.001
3.92 (2.26 to 5.57);
0.001
5.68 (3.7 to 7.67);
0.001
0.001
Adjusted Reference 2.94 (0.21 to 5.68);
0.035
4.25 (1.07 to 7.43);
0.009
3.80 (0.76 to 6.84);
0.014
5.69 (2.14 to 9.23);
0.002
0.037
BSA-indexed LV mass, g/m2 83.6  21.5 81.2  20.9 81.6  20.5 85.8  24.7 87.1  21.5 92.4  19.6
Unadjusted Reference 0.43 (1.83 to 2.71);
0.708
4.59 (1.52 to 7.66);
0.003
5.91 (2.87 to 8.93);
0.001
11.25 (7.55 to 14.94);
0.001
0.001
Adjusted Reference 0.33 (4.86 to 5.51);
0.901
4.01 (2.04 to 10.06);
0.194
6.37 (0.57 to 12.17);
0.031
6.96 (0.19 to 13.73);
0.044
0.014
LA diameter, cm 3.70  0.49 3.67  0.49 3.69  0.49 3.71  0.48 3.70  0.48 3.76  0.47
Unadjusted Reference 0.02 (0.04 to 0.07);
0.562
0.04 (0.03 to 0.10);
0.311
0.03 (0.03 to 0.10);
0.335
0.09 (0.01 to 0.17);
0.033
0.062
Adjusted Reference 0.03 (0.04 to 0.10);
0.411
0.04 (0.05 to 0.12);
0.400
0.01 (0.09 to 0.08);
0.871
0.01 (0.10 to 0.08);
0.877
0.392
Values are mean  SD unless otherwise indicated. The means for the drinking categories are unadjusted. Adjustment was made for sex, race, age, educational level, smoking, illicit drug use, hypertension,
diabetes, body mass index, dyslipidemia, “other cardiac diseases,” and for the values of each echocardiographic parameter at baseline (year 5).
BSA ¼ body surface area; CI ¼ confidence interval; LA ¼ left atrial; LV ¼ left ventricular; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction.
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1457(LV mass of 81.2  20.9 g/m2 in nondrinkers vs. 92.4 
19.6 g/m2 if >14 drinks/week; p ¼ 0.004) (Table 2,
Online Table 2).
Finally, there was a significant association of
greater LA diameter with greater alcohol consump-
tion in unadjusted analysis. However, this association
lost significance in the multivariable analyses.
INDIVIDUAL VARIATION IN LVEF, LVEDV, LV MASS,
AND LA DIAMETER DURING FOLLOW-UP. The indi-
vidual variation (year 25  year 5) change of each
participant, D in LVEF, LVEDV, and LV mass was not
significantly associated with cumulative alcohol
intake in the multiple linear regression analysis
(Table 3) and using multivariable FP (Online Table 3).
There was an association between the variation in LA
diameter and alcohol consumption in unadjusted
analyses and using inverse probability weighted
adjustment (Online Table 4).
EFFECT MODIFICATION OF SEX AND RACE. We did
not find a significant difference between women and
men or between white and black participants
regarding the relationship between cumulative
alcohol intake and the echocardiographic parameters
using multiple linear regression. Using multivariable
FP, there was a nonlinear association between alcohol
and LA diameter in women (p ¼ 0.018), not found inDownloaded for Ana Quininha (ana.quininha@chlc.min-saude.pt) at
For personal use only. No other uses withoumen (p ¼ 0.828) (Central Illustration, panel A, Online
Figure 1). An independent nonlinear association be-
tween LA diameter and alcohol was also seen in black
participants (p ¼ 0.007), but not in whites (Central
Illustration, panel B, Online Figure 1).
Regarding the individual variation in echocardio-
graphic parameters, DLVEDV in men (p ¼ 0.029) and
DLA diameter in women (p ¼ 0.007) and in African
American participants (p ¼ 0.028) showed an inde-
pendent linear association with average cumulative
alcohol intake.
TYPE OF BEVERAGE. For this analysis, we consid-
ered only the predominant beverage (either beer,
wine, or liquor—the one with a higher intake in ml of
alcohol as assessed by the questionnaires) and
excluded the individuals that had never drunk and
those who did not show any “type of beverage”
preference (n ¼ 1,174). When adjusting for cumulative
alcohol intake and covariates that related to the type
of predominant beverage taken, drinking wine or li-
quor was associated with smaller BSA-indexed
LVEDV. Drinking predominantly wine was also asso-
ciated with higher LVEF, lower BSA-indexed LV mass
and lower LA diameter than beer or liquor (Table 4).
BINGE-DRINKING. In the univariable analysis, binge-
drinking was associated with echocardiographic Hospital Centre of Central Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
t permission. Copyright ©2020. Elsevier Inc. All rights reserved.
TABLE 3 Change in Echocardiographic Parameters (Between Year 25 and Year 5) According to Alcohol Consumption
Total
Model 1: Standard Drinks per Week





p ValueNone >0 and <4 $4 and <7 $7 and <14 $14
DLVEF, %
(n ¼ 1,067)
2.88  15.15 3.96  26.27 2.68  8.79 3.15  7.81 1.86  8.30 2.13  7.92
Unadjusted Reference 1.28 (1.10 to 3.65);
0.292
0.81 (2.46 to 4.08);
0.628
2.10 (1.08 to 5.27);
0.196
1.82 (2.0 to 5.66);
0.350
0.309
Adjusted Reference 0.95 (1.75 to 3.66);
0.489
0.72 (4.01 to 2.57);
0.668
1.64 (1.52 to 4.78);
0.307





10.2 7  29.54 8.03 
26.90
11.46  29.34 11.06  28.68 11.13  31.09 13.33  28.42
Unadjusted Reference 3.43 (7.85 to 0.99);
0.128
3.03 (9.11 to 3.04);
0.328
3.11 (9.01 to 2.80);
0.303
5.30 (12.45 to 1.84);
0.145
0.134
Adjusted Reference 2.21 (11.39 to 6.98);
0.637









22.18  46.14 24.54  46.27 20.50  44.96 22.15  49.59 21.67  46.73 23.79  45.03
Unadjusted Reference 4.04 (9.07 to 0.99);
0.116
2.39 (9.23 to 4.45);
0.493
2.87 (9.55 to 3.81);
0.399
0.74 (8.94 to 7.45);
0.858
0.659
Adjusted Reference 0.49 (12.27 to 11.29);
0.935
2.27 (11.52 to 16.06);
0.746
5.51 (7.75 to 18.76);
0.415





0.18  0.50 0.21  0.50 0.18  0.50 0.17  0.50 0.14  0.45 0.13  0.52
Unadjusted Reference 0.026 (0.078 to 0.025);
0.318




0.077 (0.159 to 0.005);
0.066
0.043
Adjusted Reference 0.029 (0.040 to 0.099);
0.409
0.036 (0.047 to 0.119);
0.395
0.007 (0.089 to 0.076);
0.873
0.007 (0.099 to 0.085);
0.879
0.392
Values are mean  SD unless otherwise indicated. The means presented for the drinking categories are unadjusted. Adjustment was made for sex, race, age, educational level, smoking, illicit drug use,
hypertension, diabetes, body mass index, dyslipidemia, “other cardiac diseases,” and for the values of each parameter at baseline (year 5).
Abbreviations as in Table 2.
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Downloaded foparameters of cardiac remodeling (higher LVEDV, LV
mass, and LA diameter); however, when adjusting for
covariates that were associated with binge-drinking
habits, only a borderline association with LA diam-
eter was found (Table 5).
DISCUSSION
We intended to study the effects of alcohol intake on
cardiac remodeling and function over time in a
healthy sample of young adults up to middle age in
the CARDIA cohort. In our study, greater alcohol
consumption was associated with higher values of
indexed LV mass and LVEDV, suggesting that alcohol
may cause LV remodeling, which can be detrimental
(25,26,30,31).
The absolute changes in echocardiographic pa-
rameters were small, and overall, the values
remained within normal limits. Therefore, our results
reinforce the concept that mild alcohol consumption
(<7 drinks per week) poses little cardiovascular risk.
The fact that we did not find a significant asso-
ciation between alcohol and the intraindividual
variation of the echocardiographic parametersr Ana Quininha (ana.quininha@chlc.min-saude.pt) at Hospital Centre of Cent
For personal use only. No other uses without permission. Copyright(between year 25 and year 5) is probably due to the
fact that we could only calculate the variation in
LVED and LVEF in approximately one-half the
sample (in 1,073 participants for LVEDV and in 1,067
for LVEF), because the quantification methods were
different.
The fact that our sample was relatively young and
included few individuals with very high alcohol
intake might have contributed to the modest associ-
ation between alcohol and echocardiographic
changes. In our cohort, only 16 patients developed
heart failure, and 4 patients had cardiovascular
death. Our results also support the idea that the
pathogenic role of alcohol in the development of
dilated cardiomyopathy may be influenced by other
individual factors, for example, genetic predisposi-
tion, and may be less easily detected in the general
population in the absence of that data.
Another gap in the scientific evidence concerns the
existence of a threshold for ethanol cardiotoxicity,
whether it is modified by the type of beverage and
whether there are specific groups of the population
(e.g., in terms of race or sex who may be particularly
susceptible to its effects).ral Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
 ©2020. Elsevier Inc. All rights reserved.
CENTRAL ILLUSTRATION Alcohol Intake and Cardiac Remodeling
Female Male
White Black
Indexed Left Ventricular End-Diastolic
Volume (LVEDV)
(By Sex)
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Rodrigues, P. et al. J Am Coll Cardiol. 2018;72(13):1452–62.
Relationship between average alcohol intake and body surface area–indexed left ventricular (LV) end-diastolic volume (LVEDV) and mass, according to sex (A) and race
(B). In A, males are represented in orange and females in blue. In B, black participants are represented in orange, and white participants in blue. Regression coefficient
and p values for each subgroup are shown; 95% confidence intervals are represented by dashed lines. Adjustment was made for age, sex, race, educational level,
smoking, illicit drug use, hypertension, diabetes, body mass index, dyslipidemia, and “other cardiac diseases” (multivariable regression using fractional polynomials).
Alcohol intake was independently associated with higher body surface area–indexed LVEDV and LV mass, in both sexes and races.
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1459Whereas information regarding the cardiac effects
of alcohol in different races is scarce, women have
shown to be more susceptible to alcohol toxic effects
in some studies (32,33). In our cohort, sex or race did
not significantly modify the relationship between
alcohol intake and echocardiographic parameters of
LV systolic function and remodeling. However, theDownloaded for Ana Quininha (ana.quininha@chlc.min-saude.pt) at
For personal use only. No other uses withoufact that very few women drank heavily may have
compromised our ability to detect a difference.
Knowledge regarding the impact of specific types
of alcoholic beverages in ventricular function and
remodeling was lacking, and the few studies that
have addressed this issue before have failed to find
any significant differences in association (34,35). Hospital Centre of Central Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
t permission. Copyright ©2020. Elsevier Inc. All rights reserved.
TABLE 4 Impact of the Type of Beverage Preference on Ventricular Remodeling
Beer (n ¼ 713) Wine (n ¼ 295) Liquor (n ¼ 166)
LVEF, % 61.15  7.33 62.61  6.90 62.19  7.19
Unadjusted Reference 1.45 (0.47 to 2.43); 0.004 1.04 (0.18 to 2.26); 0.095
Adjusted* Reference 1.38 (0.38 to 2.39); 0.007 1.08 (0.15 to 2.31); 0.085
BSA-indexed LVEDV, ml/m2 58.57  13.32 53.66  11.50 54.70  12.04
Unadjusted Reference 4.91 (6.64 to 3.18); 0.001 3.87 (6.03 to 1.72); 0.001
Adjusted* Reference 4.90 (6.64 to 3.16); 0.001 3.65 (5.78 to 1.51); 0.001
BSA-indexed LV mass, g/m2 87.94  23.44 79.86  18.15 85.85  23.25
Unadjusted Reference 8.08 (11.21 to 4.95); 0.001 2.09 (6.02 to 1.84); 0.297
Adjusted* Reference 5.78 (8.84 to 2.71); 0.001  3.75 (7.56 to 0.05); 0.053
LA diameter, cm 3.751  0.491 3.616  0.434 3.813  0.495
Unadjusted Reference 0.135 (0.201 to 0.069); 0.001 0.062 (0.020 to 0.069); 0.140
Adjusted* Reference 0.071 (0.131 to 0.011); 0.019 0.005 (0.068 to 0.079); 0.888
Values are mean  SD or regression coefficient (95% CI); p value. The predominant drink at baseline was chosen (the beverage with the intake corresponding to more milliliters
of alcohol). *Adjusted for cumulative alcohol intake and the covariates that were associated with a predominant type of drink in univariate analysis (hypertension, race, body
mass index, educational level, sleep apnea, and thyroid disease).
Abbreviations as in Table 2.
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Downloaded foHowever, in our study, drinking predominantly wine
was associated with less LV and LA dilation and
higher LVEF, an interesting finding that warrants
further confirmation. Dietary factors can also have a
confounding factor that we could not account for.
Binge drinking, a behavior previously correlated
primarily with arrhythmias, specifically atrial fibril-
lation (36), was also associated with adverse cardiac
remodeling, but only in the crude analysis. That as-
sociation lost significance when adjustment was
performed, which could be related to confounding
but also to the limited number of participants with
binge-drinking habits.
STUDY STRENGTHS AND LIMITATIONS. The major
strength of the current study was that it analyzed ainge-Drinking on Ventricular Remodeling
Non-Binge Drinkers (n ¼ 1,449) Binge Drinkers (n ¼ 300)
61.83  7.08 61.32  7.32
Reference 0.51 (1.39 to 0.38); 0.263
Reference 1.37 (2.79 to 0.06); 0.060
l/m2 55.81  12.25 58.83  14.89
Reference 3.01 (1.43 to 4.60); 0.001
Reference 1.93 (0.47 to 4.34); 0.114
g/m2 83.22  21.64 91.32  20.73
Reference 8.10 (5.20 to 10.99); 0.001
Reference 1.92 (2.40 to 6.24); 0.383
3.684  0.491 3.808  0.483
Reference 0.124 (0.062 to 0.186); 0.001
Reference 0.085 (0.001 to 0.170); 0.050
gression coefficient (95% CI); p value. *Adjusted for cumulative alcohol intake and the
iated with binge drinking in univariable analysis (illicit drug use, smoking, body mass
d thyroid disease).
e 2.
r Ana Quininha (ana.quininha@chlc.min-saude.pt) at Hospital Centre of Cent
For personal use only. No other uses without permission. Copyrightlarge race- and sex-balanced sample with a long
follow-up. Besides utilizing this large and very com-
plete dataset, we also performed a robust analysis
with multiple adjustments for covariates, in order to
minimize the likelihood of confounding.
However, we must also highlight the significant
limitations of our study and why the study should be
interpreted with caution. Firstly, because alcohol
intake was assessed using questionnaires, recall bias
may have led to an inaccurate estimation. Secondly,
in this cohort, alcohol consumption was relatively
low, with 78% of the participants drinking only up to
7 standard drinks per week. Because alcohol car-
diotoxicity is probably more striking at greater doses
(9,10), the low prevalence of at-risk drinkers (>14
drinks per week) in our sample may have limited our
power to adequately assess the risks related to heavy
alcohol consumption. A selection bias must also be
considered, because using participants who attended
the study and performed all the required evaluations
may have overrepresented certain characteristics of
the population. Finally, as with other observational
studies, the potential for unmeasured confounding
limits our ability to establish a causal relationship.
However, because long-term randomized trials
assessing the effect of alcohol consumption on LV
function would be impractical and unethical, we
consider prospective longitudinal studies such as this
one to be the most realistic study designs available to
assess the cardiac effect of alcohol intake in
populations.
The mechanisms behind the relationship between
alcohol consumption and cardiac function and
structure still need to be better understood. We still
cannot predict which patients will develop ACM and,ral Lisbon from ClinicalKey.com by Elsevier on August 13, 2020.
 ©2020. Elsevier Inc. All rights reserved.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In most middle-
aged Americans, moderate alcohol intake has no major delete-
rious effects on cardiac structure and function. There is an as-
sociation between alcohol intake and left ventricular dilatation
that could be an early form of dilated cardiomyopathy and that is
more pronounced with liquor and beer than with wine con-
sumption and with binge drinking.
TRANSLATIONAL OUTLOOK: Prospective trials of alcohol
abstinence in patients with dilated cardiomyopathy are needed
to assess the potential reversibility of alcohol toxicity, and long-
term follow-up studies of heavy drinkers could clarify modula-
tors of the effect of alcohol on the heart.
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1461beyond sex and race, there are probably genetic fac-
tors that need to be taken into consideration. Plus,
the potential for reversibility has not been adequately
studied (5). Further studies of individuals with
greater alcohol intake may help us define better pre-
vention strategies to reduce the deleterious effects of
alcohol toxicity in populations.
CONCLUSIONS
Greater alcohol intake had an independent adverse
association with ventricular structure (greater
indexed LV mass and LVEDV) after 20 years of follow-
up. This relationship was not significantly modified by
sex or race. Moreover, there was also an association
between alcohol intake and LA diameter in women
and among African American CARDIA participants.
Alcohol consumption was not significantly associ-
ated with LV systolic dysfunction measured by LVEF
in this cohort of young adults with mild-to-moderate
alcohol consumption. There was a nonsignificant
trend for a deleterious effect of binge drinking and
drinking predominantly wine was associated with
less cardiac remodeling.
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